Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
15.46
+0.42 (2.79%)
Apr 1, 2025, 2:45 PM CST
SHE:000739 Revenue
In the year 2024, Apeloa Pharmaceutical Co.,Ltd had annual revenue of 12.02B CNY with 4.77% growth. Apeloa Pharmaceutical Co.,Ltd had revenue of 2.73B in the quarter ending December 31, 2024, a decrease of -8.15%.
Revenue
12.02B
Revenue Growth
+4.77%
P/S Ratio
1.49
Revenue / Employee
1.70M
Employees
7,060
Market Cap
17.87B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12.02B | 547.70M | 4.77% |
Dec 31, 2023 | 11.47B | 929.26M | 8.81% |
Jan 1, 2023 | 10.54B | 1.60B | 17.92% |
Jan 1, 2022 | 8.94B | 1.06B | 13.49% |
Dec 31, 2020 | 7.88B | 668.96M | 9.28% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 26.00B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |